Pure red cell aplasia associated with administration of sustained-release procainamide.
Pure red cell aplasia developed in a patient with small-cell lung cancer who was also taking sustained-release procainamide. Shortly after discontinuation of the procainamide preparation, a reticulocytosis and increasing hemoglobin level were observed.
D000368:Aged; D000741:Anemia, Aplastic / Q000139:chemically induced*; D018288:Carcinoma, Small Cell / Q000188:drug therapy; D003692:Delayed-Action Preparations; D004359:Drug Therapy, Combination; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy; D011342:Procainamide / Q000008:administration & dosage / Q000009:adverse effects*
D003692:Delayed-Action Preparations; D011342:Procainamide